Prediction of mortality and heart failure hospitalisations in patients undergoing M-TEER: external validation of the COAPT risk score.
暂无分享,去创建一个
M. Metra | P. Denti | G. Tarantini | R. Citro | C. Tamburino | A. Petronio | F. Bedogni | L. Testa | F. De Marco | G. Crimi | I. Monteforte | M. Adamo | G. Chizzola | C. Godino | A. Giordano | M. Tusa | C. Giannini | M. Pighi | A. Mongiardo | E. Villa | D. Tomasoni | F. De Felice | C. Grasso | A. P. Rubbio | G. Zaccone | E. Pancaldi | M. Massussi | Antonio L Bertorelli | A. Rubbio
[1] M. Metra,et al. Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair. , 2022, The American journal of cardiology.
[2] M. Adamo,et al. A Step Forward in Risk Stratification and Patient Selection for Mitral TEER in SMR. , 2022, JACC. Cardiovascular interventions.
[3] M. Mack,et al. Prediction of Death or HF Hospitalization in Patients With Severe FMR: The COAPT Risk Score. , 2022, JACC. Cardiovascular interventions.
[4] O. Alfieri,et al. Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion. , 2022, The American journal of cardiology.
[5] A. Regueiro,et al. A Score to Assess Mortality After Percutaneous Mitral Valve Repair. , 2022, Journal of the American College of Cardiology.
[6] H. Thiele,et al. Outcomes Stratified by Adapted Inclusion Criteria After Mitral Edge-to-Edge Repair. , 2021, Journal of the American College of Cardiology.
[7] G. Nickenig,et al. Machine Learning Identifies Clinical Parameters to Predict Mortality in Patients Undergoing Transcatheter Mitral Valve Repair. , 2021, JACC. Cardiovascular interventions.
[8] J. McMurray,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.
[9] P. Denti,et al. Italian Society of Interventional Cardiology (GIse) registry Of Transcatheter treatment of mitral valve regurgitaTiOn (GIOTTO): impact of valve disease aetiology and residual mitral regurgitation after MitraClip implantation , 2021, European journal of heart failure.
[10] G. Barbati,et al. Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation , 2021, European journal of heart failure.
[11] O. Alfieri,et al. Prognostic Value of Pre-operative Atrial Fibrillation in Patients with Secondary Mitral Regurgitation Undergoing MitraClip Implantation. , 2020, The American journal of cardiology.
[12] M. Mack,et al. Impact of COPD on Outcomes After MitraClip for Secondary Mitral Regurgitation: The COAPT Trial. , 2020, JACC. Cardiovascular interventions.
[13] M. Metra,et al. COAPT-Like Profile Predicts Long-Term Outcomes in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation. , 2020, JACC. Cardiovascular interventions.
[14] B. Prendergast,et al. Predictors of Outcomes Following Transcatheter Edge-to-Edge Mitral Valve Repair. , 2020, JACC. Cardiovascular interventions.
[15] O. Alfieri,et al. Real world safety and efficacy of transcatheter mitral valve repair with MitraClip. Thirty-day results from the Italian Society of Interventional Cardiology (GIse) Registry Of Transcatheter Treatment of Mitral Valve RegurgitaTiOn (GIOTTO). , 2020, Cardiovascular revascularization medicine : including molecular interventions.
[16] D. Capodanno,et al. Five-year clinical outcomes after percutaneous edge-to-edge mitral valve repair: Insights from the multicenter GRASP-IT registry. , 2019, American heart journal.
[17] O. Alfieri,et al. Treatment of functional mitral regurgitation in chronic heart failure: can we get a ‘proof of concept’ from the MITRA‐FR and COAPT trials? , 2019, European journal of heart failure.
[18] A. Colombo,et al. Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy. , 2018, International journal of cardiology.
[19] S. Buccheri,et al. A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation. , 2017, The American journal of cardiology.
[20] P. Boekstegers,et al. One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry , 2015, European heart journal.
[21] G. Filippatos,et al. Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium. , 2015, Journal of the American College of Cardiology.
[22] D. Capodanno,et al. Comparison of three contemporary surgical scores for predicting all-cause mortality of patients undergoing percutaneous mitral valve repair with the MitraClip system (from the multicenter GRASP-IT registry). , 2015, The American journal of cardiology.
[23] J. Wahlberg. Prevention and Rehabilitation , 2004 .